The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Moed Samuel J since 2013.
The trader's CIK number is 1561017.
At the time of the last reporting, Moed Samuel J was the SVP, Strat Plan & Analysis of Bristol Myers Squibb Co. (stock ticker symbol BMY).
Also see all insider trading activities at Bristol Myers Squibb Co.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | BMY | 0 | $0 | 36,292 | $2,242,261 | 40,472 | $618,547 |
| 2014 | BMY | 0 | $0 | 25,752 | $1,270,037 | 42,075 | $530,746 |
| 2013 | BMY | 0 | $0 | 58,898 | $2,790,587 | 81,461 | $1,528,343 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-03-13 | BMY | Sale | 591 | 66.67 | 39,401 |
| 2015-03-10 | BMY | Option Ex | 2,068 | .00 | 0 |
| 2015-03-10 | BMY | Sale | 10,343 | 65.84 | 680,941 |
| 2015-03-06 | BMY | Option Ex | 1,043 | .00 | 0 |
| 2015-03-02 | BMY | Option Ex | 1,174 | .00 | 0 |
| 2015-03-02 | BMY | Option Ex | 8,249 | .00 | 0 |
| 2015-02-12 | BMY | Sale | 3,880 | 59.26 | 229,932 |
| 2015-02-06 | BMY | Option Ex | 27,938 | 22.14 | 618,547 |
| 2015-02-06 | BMY | Sale | 21,478 | 60.15 | 1,291,987 |
| 2014-07-28 | BMY | Option Ex | 19,650 | 27.01 | 530,746 |
| 2014-07-28 | BMY | Sale | 25,752 | 49.32 | 1,270,037 |
| 2014-05-01 | BMY | Option Ex | 5,000 | .00 | 0 |
| 2014-03-10 | BMY | Option Ex | 1,173 | .00 | 0 |
| 2014-03-06 | BMY | Option Ex | 1,043 | .00 | 0 |
| 2014-03-03 | BMY | Option Ex | 15,209 | .00 | 0 |
| 2013-06-04 | BMY | Sale | 58,898 | 47.38 | 2,790,587 |
| 2013-06-04 | BMY | Option Ex | 60,100 | 25.43 | 1,528,343 |
| 2013-05-01 | BMY | Option Ex | 5,000 | .00 | 0 |
| 2013-03-07 | BMY | Option Ex | 14,425 | .00 | 0 |
| 2013-03-03 | BMY | Option Ex | 1,936 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Moed Samuel J (SVP, Strat Plan & Analysis of Bristol Myers Squibb Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.